New oral drug ICM20 tested for safety in chagas patients
Disease control
Completed
This early-stage study tested the safety of an oral drug called ICM20 in 13 adults with Chagas disease, a parasitic infection. Participants took the drug for up to 60 days while doctors monitored for side effects. The goal was to see if ICM20 is safe enough to study further.
Phase: PHASE1 • Sponsor: IC-MedTech Corporation • Aim: Disease control
Last updated May 05, 2026 11:54 UTC